The Missing Pieces: How Rare Disease Diagnoses Come Together
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million...
Know what others can’t: Real-world data gaps holding commercial teams back
The therapeutic market that you know is shaped by the healthcare data that you can see. But when critical medical, specialty, clinical or longitudinal signals are absent from that view, the picture (and the decisions based on it) is less clear. ...
Disrupting Healthcare Audiences: A new standard for precision and accuracy
"Healthcare audience targeting has changed fast, and expectations have climbed even faster." As...
.png)
Building guardrails for AI-driven real-world data programs
AI is rapidly reshaping how real-world data (RWD) is generated and analyzed across healthcare...
5 questions RWE & HEOR teams should ask data vendors in an RFP
RWE and HEOR teams face increasing pressure to produce evidence that holds up beyond internal...
Primary biliary cholangitis: Disease burden, treatments and RWD gaps
What real-world data reveals about the unique challenges of studying rare disease Primary biliary...
Insights in healthcare marketing start with truth, not inference
Healthcare marketing has reached an inflection point and for years, success was defined by reach:...
Measuring psoriasis severity, outcomes and comorbidities using real-world data
Capturing the true complexity of psoriasis in the real world Psoriasis is a common chronic...
How GLP-1 direct-to-consumer programs are distorting utilization trends
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...
GLP-1 persistence: What semaglutide data reveals about patient behavior
As the new year begins, many patients refocus on weight management and long-term health goals. At...
AI trends shaping healthcare in 2026: agentic, physical & sovereign AI
Artificial intelligence is no longer something healthcare and life sciences teams are testing on...